These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36741761)

  • 1. Enhancing and stabilizing monoclonal antibody production by Chinese hamster ovary (CHO) cells with optimized perfusion culture strategies.
    Liang K; Luo H; Li Q
    Front Bioeng Biotechnol; 2023; 11():1112349. PubMed ID: 36741761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of medium with perfusion microbioreactors for high density CHO cell cultures at very low renewal rate aided by design of experiments.
    Schwarz H; Lee K; Castan A; Chotteau V
    Biotechnol Bioeng; 2023 Sep; 120(9):2523-2541. PubMed ID: 37079436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfusion seed cultures improve biopharmaceutical fed-batch production capacity and product quality.
    Yang WC; Lu J; Kwiatkowski C; Yuan H; Kshirsagar R; Ryll T; Huang YM
    Biotechnol Prog; 2014; 30(3):616-25. PubMed ID: 24574326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a cell-once-through perfusion strategy for production of recombinant antibody from rCHO cells in a Centritech Lab II centrifuge system.
    Kim BJ; Chang HN; Oh DJ
    Biotechnol Prog; 2007; 23(5):1186-97. PubMed ID: 17691812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation and modeling of monoclonal antibody N-linked glycosylation in mammalian cell perfusion reactors.
    Karst DJ; Scibona E; Serra E; Bielser JM; Souquet J; Stettler M; Broly H; Soos M; Morbidelli M; Villiger TK
    Biotechnol Bioeng; 2017 Sep; 114(9):1978-1990. PubMed ID: 28409838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulating and optimizing Pluronic F-68 concentrations and feeding for intensified perfusion Chinese hamster ovary cell cultures.
    Wei Z; Xia Y; Su Y; Quan Y; Sun L; Wang S; Zhu F; Chen Z; Tian J; Wang WC; Zhou W; Yu H
    Biotechnol Prog; 2023; 39(4):e3340. PubMed ID: 36970759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioreactor productivity and media cost comparison for different intensified cell culture processes.
    Xu S; Gavin J; Jiang R; Chen H
    Biotechnol Prog; 2017 Jul; 33(4):867-878. PubMed ID: 27977910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impacts on product quality attributes of monoclonal antibodies produced in CHO cell bioreactor cultures during intentional mycoplasma contamination events.
    Fratz-Berilla EJ; Angart P; Graham RJ; Powers DN; Mohammad A; Kohnhorst C; Faison T; Velugula-Yellela SR; Trunfio N; Agarabi C
    Biotechnol Bioeng; 2020 Sep; 117(9):2802-2815. PubMed ID: 32436993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective temperature shift strategy development and scale confirmation for simultaneous optimization of protein productivity and quality in Chinese hamster ovary cells.
    McHugh KP; Xu J; Aron KL; Borys MC; Li ZJ
    Biotechnol Prog; 2020 May; 36(3):e2959. PubMed ID: 31930722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited use of Centritech Lab II Centrifuge in perfusion culture of rCHO cells for the production of recombinant antibody.
    Kim BJ; Oh DJ; Chang HN
    Biotechnol Prog; 2008; 24(1):166-74. PubMed ID: 18092799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of hydrolysates on monoclonal antibody productivity, purification and quality in Chinese hamster ovary cells.
    Ho SC; Nian R; Woen S; Chng J; Zhang P; Yang Y
    J Biosci Bioeng; 2016 Oct; 122(4):499-506. PubMed ID: 27067279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QbD-guided pharmaceutical development of Pembrolizumab biosimilar candidate PSG-024 propelled to industry meeting primary requirements of comparability to Keytruda®.
    Jaffar-Aghaei M; Khanipour F; Maghsoudi A; Sarvestani R; Mohammadian M; Maleki M; Havasi F; Rahmani H; Karagah AH; Kazemali MR
    Eur J Pharm Sci; 2022 Jun; 173():106171. PubMed ID: 35378209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential gene expression of a feed-spiked super-producing CHO cell line.
    Reinhart D; Damjanovic L; Castan A; Ernst W; Kunert R
    J Biotechnol; 2018 Nov; 285():23-37. PubMed ID: 30157452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a shake tube-based scale-down model for perfusion cultures.
    Wolf MKF; Lorenz V; Karst DJ; Souquet J; Broly H; Morbidelli M
    Biotechnol Bioeng; 2018 Nov; 115(11):2703-2713. PubMed ID: 30039852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid and glucose metabolism in fed-batch CHO cell culture affects antibody production and glycosylation.
    Fan Y; Jimenez Del Val I; Müller C; Wagtberg Sen J; Rasmussen SK; Kontoravdi C; Weilguny D; Andersen MR
    Biotechnol Bioeng; 2015 Mar; 112(3):521-35. PubMed ID: 25220616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very high cell density perfusion of CHO cells anchored in a non-woven matrix-based bioreactor.
    Zhang Y; Stobbe P; Silvander CO; Chotteau V
    J Biotechnol; 2015 Nov; 213():28-41. PubMed ID: 26211737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioprocess development for the production of mouse-human chimeric anti-epidermal growth factor receptor vIII antibody C12 by suspension culture of recombinant Chinese hamster ovary cells.
    Hu S; Deng L; Wang H; Zhuang Y; Chu J; Zhang S; Li Z; Guo M
    Cytotechnology; 2011 May; 63(3):247-58. PubMed ID: 21298341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-1 Perfusion Platform Development Using a Capacitance Probe for Biomanufacturing.
    Rittershaus ESC; Rehmann MS; Xu J; He Q; Hill C; Swanberg J; Borys MC; Li ZJ; Khetan A
    Bioengineering (Basel); 2022 Mar; 9(4):. PubMed ID: 35447688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Principles and approach to developing mammalian cell culture media for high cell density perfusion process leveraging established fed-batch media.
    Lin H; Leighty RW; Godfrey S; Wang SB
    Biotechnol Prog; 2017 Jul; 33(4):891-901. PubMed ID: 28371394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a chemically defined platform fed-batch culture media for monoclonal antibody-producing CHO cell lines with optimized choline content.
    Kuwae S; Miyakawa I; Doi T
    Cytotechnology; 2018 Jun; 70(3):939-948. PubMed ID: 29322349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.